From December 7 to 10, 2023, the 18th Annual Conference of the Chinese Dermatologist Association & National Conference on Cosmetic Dermatology (CDA 2023), hosted by the Chinese Medical Doctor Association and its Dermatologist Branch, was grandly held at the National Exhibition and Convention Center in Shanghai.
Under the theme of “Inheriting Excellence, Innovating for Progress,” JALA Group’s two brands, Biorrier and imine, made their debut at the 18th CDA conference. They engaged with nearly 10,000 dermatologists nationwide to discuss breakthroughs and advancements in dermatology, earning widespread recognition for their exceptional product efficacy and technological prowess.
Dedicated to Healthy Skin Science
Biorrier Presents Cutting-Edge Research Achievements
As a featured functional skincare brand at CDA, Biorrier showcased its latest research findings during a dedicated satellite symposium on the first day. The event included in-depth discussions and insights from leading Chinese dermatology experts.
Professor Xiang Leihong, Fudan University Affiliated Huashan Hospital
Professor Yang Bin, Southern Medical University Dermatology Hospital
Professor Yin Rui, Southwest Hospital of Army Medical University
Professor Xiang Leihong delivered the opening remarks, while Professor Yin Rui presented research advancements on the efficacy of Lulang Hot Spring Water—a core ingredient—in soothing redness and repairing sensitive skin. These findings reaffirmed the outstanding performance of Biorrier 728 Cream (ANTI-SENSITIVE REPAIRING CREAM) in addressing sensitive skin concerns.
Biorrier’s Star Product 728 Cream (ANTI-SENSITIVE REPAIRING CREAM) is formulated with a minimalist approach, featuring the brand’s exclusive Lulang Hot Spring Water and patented redness-reducing ingredients. Clinically validated by the Shanghai Skin Disease Hospital, it demonstrates remarkable efficacy in “reducing redness within 7 days and repairing sensitivity within 28 days.”
During the conference, Professor Wu Wenyu from Fudan University Affiliated Huashan Hospital unveiled JALA Group’s pioneering research on the application of Terminalia Chebula (“King of Tibetan Herbs”) in scalp care. The study confirmed that Terminalia Chebula extract effectively inhibits 5α-reductase activity, offering multiple benefits such as anti-hair loss, hair growth promotion, scalp anti-aging, and oil control. This sparked strong interest among attendees in scalp care products incorporating this ingredient.
Biorrier’s new scalp care line was showcased in full at its exhibition booth. The series includes three innovative products: Scalp Hair Tonic, Mild Acid Cleansing Foam, and Purifying Shampoo. Leveraging JALA Group’s exclusive “Space Care Technology,” these products feature gentle formulations and optimized packaging, specifically designed for post-transplant recovery. The cleansing foam efficiently removes impurities without excessive water rinsing, catering to sensitive scalps.
Since its inception, Biorrier has been dedicated to advancing skin health science and addressing diverse skin concerns. The brand firmly believes that healthy skin is the foundation of beauty, and visible efficacy is the essence of its products.
imine’s Debut at CDA Gains Medical Recognition
Medical-Research Collaboration Tackles Pediatric Skin Challenges
During the conference, dermatology experts gathered at imine’s dedicated satellite symposium to exchange insights on clinical practices, research advancements, and innovations in pediatric skincare formulations.
Professor Wang Liuhui, Director of the Dermatology Department at the National Children’s Medical Center (Fudan Pediatric Hospital), delivered a keynote lecture titled “Pediatric Skin Health and Care for Common Issues.” She analyzed the mechanisms behind pediatric skin problems and validated the efficacy of imine’s Anti-Dryness Cream and related products.
Professor Wang Liuhui, Director of the Dermatology Department at the National Children’s Medical Center (Fudan Pediatric Hospital)
imine SOOTHING PROTECTING CREAM is specifically formulated for children with dry, itchy, or red skin. Its patented core ingredient, Aibeijian, clinically proven by hospitals, effectively alleviates redness, cracking, and flaking caused by external irritants. The cream enhances hydration, strengthens the skin barrier, and is safe for newborns and children with low skin tolerance.
At the event, imine also launched its new Children’s FOAMING FACE WASH, designed for ages 3-12. This product addresses daily needs such as sweat removal, sunscreen cleansing, and dirt elimination. Formulated with gentle amino acid and glucoside surfactants, it cleanses without disrupting the skin barrier. Ingredients like dipotassium glycyrrhizate and panthenol boost hyaluronic acid production, ensuring hydration and comfort. With over 96% naturally derived ingredients and a “clean beauty” certification, it is ideal for children with sensitive skin.
With six years of dedicated research into pediatric skin health, imine has collaborated with Fudan Pediatric Hospital to establish the Joint Research Center for Pediatric Skin Health. Combining the hospital’s 71 years of clinical expertise and data from over 800 efficacy trials, the brand has developed a new generation of natural, safe, and age-specific skincare products. These formulations contain over 90% naturally derived ingredients and cater to low-tolerance skin. Moving forward, imine will continue to address critical pediatric skin concerns through medical-research partnerships, ensuring science-backed solutions for children’s healthy growth.
JALA Group remains committed to collaborating with dermatologists,
innovating from the foundation of skin health.
In the future, JALA will continue delivering effective solutions
to address diverse skin concerns, helping restore healthy vitality.
